NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 44 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,160,000 | +0.6% | 1,627,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,148,000 | +5.0% | 1,627,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,045,000 | +7.0% | 1,627,000 | +13.7% | 0.00% | 0.0% |
| Q3 2021 | $1,912,000 | -10.4% | 1,431,000 | -9.7% | 0.00% | 0.0% |
| Q2 2021 | $2,133,000 | -8.9% | 1,584,000 | -8.4% | 0.00% | -33.3% |
| Q1 2021 | $2,342,000 | -3.5% | 1,729,000 | -1.0% | 0.00% | -25.0% |
| Q4 2020 | $2,427,000 | +221.0% | 1,746,000 | +219.8% | 0.00% | +300.0% |
| Q3 2020 | $756,000 | -17.2% | 546,000 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $913,000 | -51.6% | 546,000 | -62.8% | 0.00% | -50.0% |
| Q1 2020 | $1,886,000 | +63.7% | 1,466,000 | +95.5% | 0.00% | +100.0% |
| Q4 2019 | $1,152,000 | +10.2% | 750,000 | -1.6% | 0.00% | 0.0% |
| Q3 2019 | $1,045,000 | -48.0% | 762,000 | -50.0% | 0.00% | +100.0% |
| Q2 2019 | $2,008,000 | – | 1,524,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CSS LLC/IL | 15,659,000 | $23,207,687 | 1.52% |
| SONA ASSET MANAGEMENT (US) LLC | 17,500,000 | $26,317,952 | 1.09% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 26,765,000 | $40,113,099 | 0.86% |
| Warberg Asset Management LLC | 1,271,000 | $1,885,846 | 0.38% |
| SSI INVESTMENT MANAGEMENT LLC | 2,296,000 | $3,406,116 | 0.28% |
| Paloma Partners Management Co | 3,125,000 | $4,694,590 | 0.16% |
| FRANKLIN RESOURCES INC | 54,750,000 | $81,769,125 | 0.04% |
| Rock Springs Capital Management LP | 1,000,000 | $1,497,950 | 0.04% |
| LORD, ABBETT & CO. LLC | 4,666,000 | $6,922 | 0.03% |
| D. E. Shaw & Co., Inc. | 14,351,000 | $21,373,197 | 0.02% |